Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ruthenium Catalyzed Alkylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112939892A reveals a green Ru-catalyzed route for quetiapine intermediates. Achieve high purity and yield with water as the only byproduct for cost-effective API manufacturing.
Patent CN106349102B reveals a safe ruthenium-catalyzed route for meta-alkyl azo aromatic compounds, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN112159360B details a green ruthenium-catalyzed route for triazine derivatives, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN112939892B reveals a green ruthenium-catalyzed route for quetiapine intermediates, offering high purity and cost reduction in API manufacturing for global supply chains.
Patent CN110511214A reveals a ruthenium-catalyzed route for diamine heterocycles, offering cost reduction and scalable supply for antitumor pharmaceutical intermediates.
Patent CN107089940B enables efficient meta-alkylation. This technology reduces production costs and improves supply chain reliability for high-purity pharmaceutical intermediates globally.